Novartis India Limited (BOM:500672)
1,454.05
-4.95 (-0.34%)
At close: Jul 7, 2026
Novartis India Market Cap
Novartis India has a market cap or net worth of 35.9 billion as of July 7, 2026. Its market cap has increased by 45.20% in one year.
Market Cap
35.90B
Enterprise Value
29.26B
Revenue
3.54B
Ranking
n/a
PE Ratio
38.53
Stock Price
1,454.05
Market Cap Chart
Since April 14, 1999, Novartis India's market cap has increased from 12.59B to 35.90B, an increase of 185.27%. That is a compound annual growth rate of 3.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 35.90B | 86.66% |
| Dec 31, 2025 | 19.23B | -15.31% |
| Dec 31, 2024 | 22.71B | 18.95% |
| Dec 29, 2023 | 19.09B | 14.56% |
| Dec 30, 2022 | 16.67B | -12.94% |
| Dec 31, 2021 | 19.14B | 13.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi India | 79.83B |
| FDC Limited | 69.37B |
| Bliss GVS Pharma | 54.25B |
| Gufic Biosciences | 38.38B |
| Morepen Laboratories | 33.30B |
| Unichem Laboratories | 32.67B |
| Kwality Pharmaceuticals | 27.53B |
| Hikal | 26.85B |